Cargando…
GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
Glypican-1 (GPC1) is a glycosylated protein recognized as a promising biomarker for cancer. Nonetheless, there have been few systematic studies on GPC1 in colon adenocarcinoma (COAD). We conducted bioinformatic analysis based on The Cancer Genome Atlas (TCGA) and used clinical samples to verify that...
Autores principales: | Liu, Ying, Ren, Hui, Yang, Mu-qing, Li, Ji-yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492339/ https://www.ncbi.nlm.nih.gov/pubmed/36158119 http://dx.doi.org/10.1155/2022/8209700 |
Ejemplares similares
-
GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma
por: Lin, Lumin, et al.
Publicado: (2022) -
GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021) -
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021) -
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021) -
High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
por: Zhang, Yetao, et al.
Publicado: (2023)